Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shanghai Yitai Pharmaceutical Technology

2016 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of bio-pharmaceutical services intended to develop and commercialize innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The company's bio-pharmaceutical services include developing synthetic peptide analog of human parathyroid hormone-related protein (hPTHrP) which is a bone-building hormone and product for treatment of osteoporosis in both injection and trans dermal methods of administration, enabling doctors to cure their patients quickly.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 811 Huahong Business Center
  • 388 Daduhe Road No. 5
  • Shanghai, Putuo 200062
  • China

Shanghai Yitai Pharmaceutical Technology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Shanghai Yitai Pharmaceutical Technology‘s full profile, request access.

Request full access to PitchBook